Security key
702712100
CUSIP: 702712100
Security key
702712100
Report period
Q4 2022
Institutions
64
Top holders
10
Broader feeds
Reporting periods
Recent filing periods:
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Rank 1 holder
Rank 2 holder
Rank 3 holder
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
281%
|
$11,165,000
8,931,999 shares
|
— | 30 Sep 2022 |
| Versant Venture Management, LLC |
13F
Company
|
156%
|
$6,200,000
4,959,769 shares
|
— | 30 Sep 2022 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
118%
|
$4,696,000
3,756,915 shares
|
— | 30 Sep 2022 |
| Lynx1 Capital Management LP |
13F
Company
|
86%
|
$3,441,000
2,752,422 shares
|
— | 30 Sep 2022 |
| New Leaf Venture Partners, L.L.C. |
13F
Company
|
78%
|
$3,122,000
2,497,922 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
63%
|
$2,521,000
2,017,050 shares
|
— | 30 Sep 2022 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Investor-level positions for this CUSIP, loaded as an interactive table.
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).